Keywords: Canada, EU, Trade agreement, CGPA, Rx&D, Patent system, Market exclusivity

CETA with EU would wipe out Canada’s drug savings, says generic drugmakers, but Rx& D sees benefits

Article | 09 June 2011

The European Union is in negotiations for a comprehensive economic and trade agreement (CETA) with Canada. The last round of ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in